Dr Lal PathLabs margin slips as expenses outpace revenue
Revenue rose 16.61% year on year, but net profit fell 14.98% as the tax rate moved up from last year's negative base.
Filed 30 Apr 2026, 15:21 IST · Dr Lal Pathlabs Ltd (LALPATHLAB)
Key takeaways
- Consolidated revenue grew 16.61% year on year, but expenses grew 18.98%, narrowing operating margin by 1.47 percentage points.
- Net profit fell 14.98% despite a 4.37% rise in pre-tax profit, as the tax rate increased by 18.8 percentage points from last year's negative base.
- Operating margin at 26.58% remained 3.2 percentage points above the 23.38% healthcare-peer median, despite two consecutive quarterly declines.
Price around the results
Revenue growth did not convert into operating leverage
The consolidated Q4FY26 revenue increase of 16.61% year on year translated into only 10.53% growth in operating profit. Expenses rose faster than revenue, which cut operating margin by 1.47 percentage points to 26.58%. Sequentially, revenue grew 6.5% while expenses grew 7.37%, also limiting operating-profit growth to 4.18%.
Tax reversal masked the operating result
Pre-tax profit increased 4.37% year on year, but net profit declined 14.98% as the tax rate rose by 18.8 percentage points from -1.37% in Q4FY25 to 17.43%. Other income accounted for 14.99% of pre-tax profit, so reported earnings also included a material non-operating contribution. Sequentially, the tax rate fell by 9.04 percentage points, helping net profit rise 44.64%.
Margin is still above peers but has weakened since Q2
Operating margin has declined for two straight quarters, from 30.67% in Q2FY26 to 27.17% in Q3FY26 and 26.58% in Q4FY26. The year-on-year pressure reflects expenses growing faster than revenue, while interest and depreciation also increased 22.0% and 22.53%, respectively. The margin remained 3.2 percentage points above the 23.38% median for 48 healthcare peers that had reported.
Management points to a wider collection and laboratory network
In its investor presentation, management said the company had added 32 laboratories, more than 1,900 patient service centres and 2,300 pickup points over the last two years. The expansion provides context for the company's broader operating footprint, although the quarter's expense growth still exceeded revenue growth.
The initial stock move was within its usual results range
The stock fell 2.19% on the results day, with a 0.84% opening gap lower and a 1.44% relative decline. Across eight recent result reactions, the stock has risen four times and fallen four times, with a median absolute move of 2.69%, making the initial decline ordinary by its history. It was 18.03% higher by the fifth session.
Q4FY26 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q4FY26 | Q3FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹703 cr | ₹660 cr | +6.50% | +16.61% |
| Other income | ₹24 cr | ₹-6 cr | — | -6.98% |
| Expenses | ₹516 cr | ₹481 cr | +7.37% | +18.98% |
| Operating profit | ₹187 cr | ₹179 cr | +4.18% | +10.53% |
| Operating margin (%) | 26.58% | 27.17% | — | — |
| Interest | ₹6 cr | ₹7 cr | -15.28% | +22.00% |
| Depreciation | ₹45 cr | ₹42 cr | +5.94% | +22.53% |
| Profit before tax | ₹160 cr | ₹124 cr | +28.80% | +4.37% |
| Tax | ₹28 cr | ₹33 cr | -15.20% | — |
| Net profit | ₹132 cr | ₹91 cr | +44.64% | -14.98% |
| EPS (₹) | ₹7.86 | ₹5.42 | +45.02% | -57.67% |
Operating margin of 26.58% compares with a Healthcare sector median of 23.38% across 48 peers that have reported Q4FY26.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | -2.19% | -1.44% |
| Next session | +12.56% | — |
| 5 sessions | +18.03% | +18.03% |
| 15 sessions | +16.62% | — |
| 30 sessions | +15.61% | — |
Volume on the results session was 0.88× its 20-day average.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
Expansion
- The company added 32 laboratories, more than 1,900 PSCs and 2,300 PUPs over the last two years.
What to watch
- Whether operating margin recovers from 26.58% after two consecutive quarterly declines.
- Whether expense growth falls below the 18.98% year-on-year pace after exceeding revenue growth of 16.61%.
- Whether other income's 14.99% share of pre-tax profit declines.